Lloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
Lloyd Inc is recalling 19,166 bottles of Levothroid 50 mcg tablets because they failed potency testing at 9 months.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score when no specific hospitalizations or severe injuries are reported in the source text.
Plain-English summary
Lloyd Inc is recalling 19,166 bottles of Levothroid (levothyroxine sodium tablets, USP), 50 mcg, packaged in 100-count bottles. The product is identified by NDC 0456-1321-01 and Lot 1087589. The recall was initiated because the tablets were found to be subpotent, meaning they had a low assay result at the 9-month test interval.
The affected product was distributed nationwide and in Puerto Rico. Levothroid is a prescription medication manufactured for Forest Pharmaceuticals, Inc., a subsidiary of Forest Laboratories, Inc., by Lloyd Pharmaceutical in Shenandoah, Iowa.
Consumers with this specific lot of Levothroid should contact their healthcare provider or pharmacist for guidance on obtaining a replacement or alternative treatment. The recall is classified as Class II by the FDA, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Levothroid (levothyroxine sodium tablets, USP), 50 mcg., packaged in 100-ct. bottles, RX, NDC 0456-1321-01. Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
- Manufacturer
- Lloyd Inc
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 19,166
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 1087589
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Lloyd Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Lloyd Inc
See all →- ModerateLloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
FDA (Drugs) · 2012-07-04
- ModerateLloyd Inc Recalls Subpotent Thyro-Tab 0.050mg Bulk Tablets
FDA (Drugs) · 2012-07-04
- SevereLloyd Inc Recalls Subpotent Thyro-Tab 0.75 mg Tablets
FDA (Drugs) · 2012-07-04
Same hazard · subpotent drug
See all →- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02